ALIGN TECHNOLOGY, INC. (NASDAQ:ALGN) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
ALIGN TECHNOLOGY INC Exhibit
EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFilingEXHIBIT 99.1Align Technology and Straumann Group Settle Global ClearCorrect Patent Disputes and Sign Non-Binding Letter of Intent for Straumann to Distribute iTero Scanners Straumann agrees to immediate payment of $35 million settlement to AlignAlign and Straumann to dismiss existing patent disputes in US and UKNeodent to withdraw Brazil invalidity action against AlignAlign and Straumann sign non-binding letter of intent for 5-year global distribution agreement for sale of 5,…
To view the full exhibit click here
About ALIGN TECHNOLOGY, INC. (NASDAQ:ALGN)
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Express/Lite, Teen, Assist and Vivera Retainers, along with its training and ancillary products for treating malocclusion. The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Company’s iTero scanner is used by dental professionals, and labs and services for restorative and orthodontic digital procedures, as well as Invisalign digital impression submission.
